Antonio Portolés‐Hernández

ORCID: 0000-0002-6967-9723
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments
  • Cardiac pacing and defibrillation studies
  • Cardiac Structural Anomalies and Repair
  • Nutrition and Health in Aging
  • Infective Endocarditis Diagnosis and Management
  • Cardiovascular Function and Risk Factors
  • Antibiotic Resistance in Bacteria
  • Adrenal Hormones and Disorders
  • Toxin Mechanisms and Immunotoxins
  • Neurofibromatosis and Schwannoma Cases
  • Congenital Diaphragmatic Hernia Studies
  • Antibiotics Pharmacokinetics and Efficacy
  • Neuroblastoma Research and Treatments
  • Sarcoma Diagnosis and Treatment
  • Atrial Fibrillation Management and Outcomes
  • Venous Thromboembolism Diagnosis and Management
  • Esophageal and GI Pathology
  • Microbial Natural Products and Biosynthesis
  • Bioactive Compounds and Antitumor Agents
  • Pleural and Pulmonary Diseases
  • Occupational and environmental lung diseases
  • Multiple Myeloma Research and Treatments
  • Monoclonal and Polyclonal Antibodies Research
  • Pericarditis and Cardiac Tamponade

Hospital General Universitario Gregorio Marañón
2025

Centro de Investigación Biomédica en Red
2025

Centro de Investigación en Red en Enfermedades Cardiovasculares
2025

Instituto de Salud Carlos III
2025

Hospital Universitario Puerta de Hierro Majadahonda
2020-2024

Instituto Dr. Jaime Slullitel
1967

Jörg Hausleiter Mark Lachmann Lukas Stolz Francesco Bedogni Antonio Popolo Rubbio and 95 more Rodrigo Estévez‐Loureiro Sergio Raposeiras‐Roubín Peter Boekstegers Nicole Karam Volker Rudolph Thomas J. Stocker Mathias Orban Daniel Braun Michael Näbauer Steffen Maßberg Aniela Popescu T. Ruf Ralph Stephan von Bardeleben Christos Iliadis Roman Pfister Stephan Baldus Christian Besler Tobias Kister Karl Patrik Kresoja Philipp Lurz Hölger Thiele Benedikt Koell Niklas Schofer Daniel Kalbacher Michael Neuß Christian Butter Karl‐Ludwig Laugwitz Teresa Trenkwalder Eroion Xhepa Michael Joner Hazem Omran Vera Fortmeier Muhammed Gerçek Harald Beucher Thomas Schmitz Alexander Bufe Jürgen Rothe Melchior Seyfarth Tobias Schmidt Christian Frerker Dennis Rottländer Patrick Horn Maximilian Spieker Elric Zweck Mohammad Kassar Fabien Praz Stephan Windecker Tania Puscas Marianna Adamo Laura Lupi Marco Metra Emmanuel Villa Giuseppe Biondi‐Zoccai Corrado Tamburino Carmelo Grasso Fausto Catriota Luca Testa Maurizio Tusa Cosmo Godino Michele Galasso Matteo Montorfano Eustachio Agricola Paolo Denti Federico De Marco Giuseppe Tarantini Giulia Masiero Gabriele Crimi Andrea Munafò Christina Giannini Anna Sonia Petronio Stefano Pidello Paolo Boretto Antonio Montefusco Simone Frea Filippo Angelini Pier Paolo Bocchino Francesco De Felice Rodolfo Citro Berenice Caneiro‐Queija Xavier Freixa Ander Regueiro Laura Sanchís Manel Sabaté Dabit Arzamendi Lluís Asmarats Estefanía Fernández‐Peregrina Tomas Benito‐González Felipe Fernández‐Vázquez Isaac Pascual Pablo Avanzas Luis Nombela‐Franco Gabriela Tirado‐Conte Eduardo Pozo Antonio Portolés‐Hernández Vanessa Moñivas Palomero

Abstract Background and Aims Risk stratification for mitral valve transcatheter edge-to-edge repair (M-TEER) is paramount in the decision-making process to appropriately select patients with severe secondary regurgitation (SMR). This study sought develop validate an artificial intelligence-derived risk score (EuroSMR score) predict 1-year outcomes (survival or survival + clinical improvement) SMR undergoing M-TEER. Methods An was developed from EuroSMR cohort (4172 428 treated M-TEER...

10.1093/eurheartj/ehad871 article EN European Heart Journal 2024-01-19

Background Malnutrition is associated with poor prognosis in several cardiovascular diseases. However, its prognostic impact patients undergoing transcatheter edge-to-edge mitral valve repair (TEER) not well known. This study sought to assess the prevalence, clinical associations, and consequences of malnutrition TEER. Methods Results A total 892 TEER from international MIVNUT (Mitral Valve Repair Nutritional Status) registry were studied. status was assessed Controlling Status score. The...

10.1161/jaha.121.023121 article EN cc-by-nc-nd Journal of the American Heart Association 2022-10-11

Background: Limited information has been reported regarding the impact of percutaneous mitral valve repair (PMVR) on ventricular arrhythmic (VA) burden. The aim this study was to address incidence VA and appropriate antitachycardia implantable cardiac defibrillator (ICD) therapies before after PMVR. Methods: We retrospectively analyzed all consecutive patients with heart failure reduce left ejection fraction (LVEF), functional regurgitation (FMR) grade 3+ or 4+ an active ICD resynchronizer...

10.21037/atm.2020.02.45 article EN Annals of Translational Medicine 2020-08-01

Abstract Funding Acknowledgements Type of funding sources: None. Introduction The most frequent complications atrial fibrillation (AF) ablation procedures are those related to the vascular access site, which associated with increased morbidity and length hospital stay. Purpose: To assess safety efficacy venous site closure a suture-mediated device (SVD), as well feasibility early mobilization same-day discharge protocol after AF procedures. Methods: We conducted retrospective analysis all...

10.1093/europace/euab116.291 article EN EP Europace 2021-05-01

Abstract Background Limited information has been reported regarding the impact of percutaneous mitral valve repair (PMVR) on ventricular arrhythmic (VA) burden. The aim this study was to address incidence VA and appropriate antitachycardia implantable cardiac defibrillator (ICD) therapies before after PMVR. Methods We retrospectively analyzed all consecutive patients with heart failure reduce left ejection fraction, functional regurgitation grade 3+ or 4+ an active ICD resynchronizer who...

10.1093/ehjci/ehaa946.2636 article EN European Heart Journal 2020-11-01
Coming Soon ...